Results 11 to 20 of about 1,698,727 (261)

HCV 3a core protein increases lipid droplet cholesteryl ester content via a mechanism dependent on sphingolipid biosynthesis.

open access: yesPLoS ONE, 2014
Hepatitis C virus (HCV) infected patients often develop steatosis and the HCV core protein alone can induce this phenomenon. To gain new insights into the pathways leading to steatosis, we performed lipidomic profiling of HCV core protein expressing-Huh ...
Ursula Loizides-Mangold   +8 more
doaj   +2 more sources

Critical role of neutral cholesteryl ester hydrolase 1 in cholesteryl ester hydrolysis in murine macrophages [PDF]

open access: yesJournal of Lipid Research, 2014
Hydrolysis of intracellular cholesteryl ester (CE) is the rate-limiting step in the efflux of cholesterol from macrophage foam cells. In mouse peritoneal macrophages (MPMs), this process is thought to involve several enzymes: hormone-sensitive lipase (Lipe), carboxylesterase 3 (Ces3), neutral CE hydrolase 1 (Nceh1).
Kent Sakai   +10 more
openaire   +4 more sources

C323 of SR-BI is required for SR-BI-mediated HDL binding and cholesteryl ester uptake[S]

open access: yesJournal of Lipid Research, 2011
Scavenger receptor BI (SR-BI) is an HDL receptor. It binds HDL and mediates the uptake of cholesteryl ester from HDL. Early studies have pointed out that the extracellular domain of SR-BI is critical for SR-BI-mediated cholesteryl ester uptake.
Ling Guo   +4 more
doaj   +2 more sources

Prostate cancer cell proliferation is influenced by LDL-cholesterol availability and cholesteryl ester turnover. [PDF]

open access: yesCancer Metab, 2022
Background Prostate cancer growth is driven by androgen receptor signaling, and advanced disease is initially treatable by depleting circulating androgens.
Raftopulos NL   +19 more
europepmc   +2 more sources

Cholesteryl ester transfer protein (CETP) as a drug target for cardiovascular disease

open access: yesNature Communications, 2021
Development of cholesteryl ester transfer protein (CETP) inhibitors for coronary heart disease (CHD) has yet to deliver licensed medicines. To distinguish compound from drug target failure, we compared evidence from clinical trials and drug target ...
A. Schmidt   +22 more
semanticscholar   +1 more source

Apolipoprotein F is reduced in humans with steatosis and controls plasma triglyceride‐rich lipoprotein metabolism

open access: yesHepatology, EarlyView., 2022
Hepatic APOF transcript levels correlate inversely with plasma TG and hepatic steatosis in humans. ApoF expression in mice promotes VLDL‐TG production and lipoprotein remnant clearance in mice. Abstract Background NAFLD affects nearly 25% of the global population. Cardiovascular disease (CVD) is the most common cause of death among patients with NAFLD,
Audrey Deprince   +30 more
wiley   +1 more source

Bolstering cholesteryl ester hydrolysis in liver: A hepatocyte-targeting gene delivery strategy for potential alleviation of atherosclerosis [PDF]

open access: yes, 2017
Current atherosclerosis treatment strategies primarily focus on limiting further cholesteryl esters (CE) accumulation by reducing endogenous synthesis of cholesterol in the liver.
Ghosh, Shobha   +5 more
core   +2 more sources

Purification and characterization of lipid transfer protein(s) from human lipoprotein-deficient plasma

open access: yesJournal of Lipid Research, 1982
Lipid transfer activities from human plasma have been characterized to determine whether triglyceride and cholesteryl ester transfer proteins are identical.
R E Morton, D B Zilversmit
doaj   +1 more source

Home - About - Disclaimer - Privacy